During the upscaling process, Polyrizon and its manufacturing partner successfully transitioned from small-batch laboratory production to a larger-scale, controlled manufacturing run designed to ...

At GIJC25, Peruvian investigative journalist Fabiola Torres showed reporters how to uncover the systems behind pharma ...

Union Minister Piyush Goyal met with Indian pharmaceutical stakeholders to boost industry growth and refine regulations.

The drugmaker says an oral version of Wegovy improved Alzheimer’s-related biomarkers, but didn’t delay the disease’s ...

The market for GLP-1 medications is already huge, and is expected to explode. It was valued at about $52 billion in 2024; ...

Beyond epinephrine, the same powder-based platform underlies early-stage pipeline programs in nausea and vomiting induced by chemotherapy, reinforcing that this is not a single-product story but a ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

HHS Secretary Robert F. Kennedy Jr. takes near-daily calls with President Donald Trump, with aides sitting on the floor and ...

Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big ...

New investor AXA IM Alts joins upsized Series B round to support clinical advancement and expand global health impact of ninerafaxstat, a novel ...

Novo Nordisk A/S (NYSE: NVO) announced on Monday that Wegovy (semaglutide) injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited-time price of $199 per month to new self-pay patients ...